| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.097 | 0.03 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |